Jointown Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 5/6
Jointown Pharmaceutical Group has a total shareholder equity of CN¥32.8B and total debt of CN¥14.1B, which brings its debt-to-equity ratio to 43.1%. Its total assets and total liabilities are CN¥101.0B and CN¥68.2B respectively. Jointown Pharmaceutical Group's EBIT is CN¥4.1B making its interest coverage ratio 4.1. It has cash and short-term investments of CN¥16.2B.
Key information
43.1%
Debt to equity ratio
CN¥14.14b
Debt
| Interest coverage ratio | 4.1x |
| Cash | CN¥16.24b |
| Equity | CN¥32.81b |
| Total liabilities | CN¥68.21b |
| Total assets | CN¥101.02b |
Recent financial health updates
We Think Jointown Pharmaceutical Group (SHSE:600998) Can Stay On Top Of Its Debt
Nov 17
These 4 Measures Indicate That Jointown Pharmaceutical Group (SHSE:600998) Is Using Debt Reasonably Well
Aug 01Recent updates
We Think Jointown Pharmaceutical Group (SHSE:600998) Can Stay On Top Of Its Debt
Nov 17Here's What Analysts Are Forecasting For Jointown Pharmaceutical Group Co., Ltd (SHSE:600998) Following Its Earnings Miss
Aug 29Earnings Working Against Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Share Price
Aug 26These 4 Measures Indicate That Jointown Pharmaceutical Group (SHSE:600998) Is Using Debt Reasonably Well
Aug 01Jointown Pharmaceutical Group (SHSE:600998) Has More To Do To Multiply In Value Going Forward
Jun 07Jointown Pharmaceutical Group Co., Ltd's (SHSE:600998) Earnings Are Not Doing Enough For Some Investors
May 21Calculating The Intrinsic Value Of Jointown Pharmaceutical Group Co., Ltd (SHSE:600998)
Apr 05Financial Position Analysis
Short Term Liabilities: 600998's short term assets (CN¥83.1B) exceed its short term liabilities (CN¥65.7B).
Long Term Liabilities: 600998's short term assets (CN¥83.1B) exceed its long term liabilities (CN¥2.5B).
Debt to Equity History and Analysis
Debt Level: 600998 has more cash than its total debt.
Reducing Debt: 600998's debt to equity ratio has reduced from 87.6% to 43.1% over the past 5 years.
Debt Coverage: 600998's debt is not well covered by operating cash flow (9.1%).
Interest Coverage: 600998's interest payments on its debt are well covered by EBIT (4.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 03:43 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jointown Pharmaceutical Group Co., Ltd is covered by 19 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shaoling Wang | Chasing Securities |
| Fusheng Cheung | China Galaxy International Securities (Hong Kong) |
| Pei Cheng | China Galaxy Securities Co., Ltd. |